Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pharming Group N.V (PHAR) Return on Assets: 2021-2025

Historic Return on Assets for Pharming Group N.V (PHAR) over the last 4 years, with Sep 2025 value amounting to 0.25%.

  • Pharming Group N.V's Return on Assets rose 31.00% to 0.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25%, marking a year-over-year increase of 31.00%. This contributed to the annual value of -0.03% for FY2024, which is 2.00% down from last year.
  • According to the latest figures from Q3 2025, Pharming Group N.V's Return on Assets is 0.25%, which was up 3,539.81% from 0.01% recorded in Q2 2025.
  • In the past 5 years, Pharming Group N.V's Return on Assets ranged from a high of 0.25% in Q3 2025 and a low of -0.08% during Q2 2024.
  • Moreover, its 3-year median value for Return on Assets was -0.05% (2023), whereas its average is -0.01%.
  • Its Return on Assets has fluctuated over the past 5 years, first dropped by 28bps in 2023, then soared by 31bps in 2025.
  • Over the past 5 years, Pharming Group N.V's Return on Assets (Quarterly) stood at 0.01% in 2021, then increased by 15bps to 0.16% in 2022, then decreased by 21bps to -0.05% in 2023, then decreased by 2bps to -0.07% in 2024, then skyrocketed by 31bps to 0.25% in 2025.
  • Its last three reported values are 0.25% in Q3 2025, 0.01% for Q2 2025, and -0.07% during Q4 2024.